The retinoblastoma (RB) susceptibility gene was the first tumour-suppressor gene isolated, is located on human chromosome 13ql4 (Sparkes et al., 1980) and consists of 27 exons (McGee et al., 1989) . This gene encodes a nuclear phosphoprotein that regulates the cell cycle and forms protein complexes with the adenovirus ElA and SV40 large T oncoproteins (Goodrich et al., 1991) . Functional loss of the RB gene is thought to be involved in the initiation and/or progression of many human cancers.
Various studies have revealed that the inactivation of the RB gene has important roles in the development of several types of human tumours, including retinoblastoma (Friend et al., 1986; Fung et al., 1987; Lee et al., 1987) , osteosarcoma (Friend et al., 1986; Fung et al., 1987; Toguchida et al., 1988) , lung cancer (Harbour et al., 1988; Yandell et al., 1989; Horowitz et al., 1990; Mori et al., 1990) , breast cancer (T'Ang et al., 1988; Varley et al., 1989) and prostate cancer (Bookstein et al., 1990) . Similarly, several studies have revealed that human bladder cancers have altered or absent RB protein, or loss of heterozygosity (LOH) at the RB locus (Horowitz et al., 1990; Cairns et al., 1991; Ishikawa et al., 1991 : Presti et al., 1991 Xu et al., 1993) . Takahashi et al. (1991) and Goodrich et al. (1992) showed that the RB gene transfected into bladder cancer cells suppressed tumorigenicity, suggesting this gene is critical in bladder cancer development. Xu et al. (1993) segments ( Figure 1 , Table II Table I . SSCP analysis revealed ten tumour samples suggestive of a mutation (Figure 2 ). Sequence studies of these ten PCR products revealed single missense mutations in five samples, small deletions in three samples ( (Zhang et al., 1994) . Therefore, immunohistochemical analysis should be performed both to clarify the relative value of these approaches and to strengthen the significance of the observation of RB mutations.
Finally, coexistence of abnormalities of multiple tumoursuppressor genes are commonly found in cancers (Murakami et al., 1991) , and cooperative roles for the RB and the p53 genes have been suggested (Shay et al., 1991) . Further studies are required to clarify the multistep process of bladder cancer development in relation to the alterations of tumoursuppressor genes, and it will be interesting to see whether mutations of the RB gene as well as other tumour-suppressor genes can be used as clinical predictors for determining prognosis and guiding treatment in patients with bladder cancer.
